These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17958515)

  • 1. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease.
    Weksler BB
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():13-9. PubMed ID: 17958515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection.
    Afdhal NH; McHutchison JG
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():29-39. PubMed ID: 17958517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases.
    Sanjo A; Satoi J; Ohnishi A; Maruno J; Fukata M; Suzuki N
    J Gastroenterol Hepatol; 2003 Jun; 18(6):638-44. PubMed ID: 12753144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenia associated with chronic liver disease.
    Afdhal N; McHutchison J; Brown R; Jacobson I; Manns M; Poordad F; Weksler B; Esteban R
    J Hepatol; 2008 Jun; 48(6):1000-7. PubMed ID: 18433919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C.
    Dusheiko G
    Clin Liver Dis; 2009 Aug; 13(3):487-501. PubMed ID: 19628164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C.
    Peck-Radosavljevic M; Wichlas M; Pidlich J; Sims P; Meng G; Zacherl J; Garg S; Datz C; Gangl A; Ferenci P
    Hepatology; 1998 Nov; 28(5):1424-9. PubMed ID: 9794931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: thrombocytopenia in chronic liver disease.
    Poordad F
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():5-11. PubMed ID: 17958514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C-associated thrombocytopenia: aetiology and management.
    Fouad YM
    Trop Gastroenterol; 2013; 34(2):58-67. PubMed ID: 24377151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.
    Iga D; Tomimatsu M; Endo H; Ohkawa S; Yamada O
    Eur J Haematol; 2005 Nov; 75(5):417-23. PubMed ID: 16191092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
    McHutchison JG; Dusheiko G; Shiffman ML; Rodriguez-Torres M; Sigal S; Bourliere M; Berg T; Gordon SC; Campbell FM; Theodore D; Blackman N; Jenkins J; Afdhal NH;
    N Engl J Med; 2007 Nov; 357(22):2227-36. PubMed ID: 18046027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia in chronic liver disease.
    Peck-Radosavljevic M
    Liver Int; 2017 Jun; 37(6):778-793. PubMed ID: 27860293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia.
    Aref S; Mabed M; Selim T; Goda T; Khafagy N
    Hematology; 2004; 9(5-6):351-6. PubMed ID: 15763973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction.
    Zucker ML; Hagedorn CH; Murphy CA; Stanley S; Reid KJ; Skikne BS
    Int J Lab Hematol; 2012 Oct; 34(5):525-32. PubMed ID: 22708981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an immunological pathogenesis of thrombocytopenia in chronic liver disease.
    Kajiwara E; Akagi K; Azuma K; Onoyama K; Fujishima M
    Am J Gastroenterol; 1995 Jun; 90(6):962-6. PubMed ID: 7771431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease.
    de Noronha R; Taylor BA; Wild G; Triger DR; Greaves M
    Clin Lab Haematol; 1991; 13(2):127-35. PubMed ID: 1934923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety of pegylated interferon in patients with hepatitis C virus induced cirrhosis].
    Gasztonyi B; Pár G; Pár A; Hunyady B
    Orv Hetil; 2005 Nov; 146(48):2431-4. PubMed ID: 16408382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune thrombocytopenia and alpha-interferon therapy.
    Dourakis SP; Deutsch M; Hadziyannis SJ
    J Hepatol; 1996 Dec; 25(6):972-5. PubMed ID: 9007728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of thrombocytopenia in advanced liver disease.
    Gangireddy VG; Kanneganti PC; Sridhar S; Talla S; Coleman T
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):558-64. PubMed ID: 25222481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hepatitis C in patients on renal replacement therapy].
    Tornai I; Mátyus J
    Orv Hetil; 2007 Mar; 148(11):489-94. PubMed ID: 17350920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet Dysfunction: Status of Thrombopoietin in Thrombocytopenia Associated with Chronic Liver Failure.
    Giannini EG; Peck-Radosavljevic M
    Semin Thromb Hemost; 2015 Jul; 41(5):455-61. PubMed ID: 26049067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.